Increased faecal serine protease activity in diarrhoeic lBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity

Gecse, K.; Aóka, A.; Ferrier, L.; Leveque, M.; Eutamene, H.; Cartier, C.; Aet-Belgnaoui, A.; Rosztóczy, A.; Izbéki, F.; Fioramonti, J.; Wittmann, T.; Bueno, L.
May 2008
Gut;May2008, Vol. 57 Issue 5, p591
Academic Journal
OBJECTIVES: Diarrhoea-predominant irritable bowel syndrome (IBS-D) is characterised by elevated colonic lumenal serine protease activity. The aims of this study were (1) to investigate the origin of this elevated serine protease activity, (2) to evaluate if it may be sufficient to trigger alterations in colonic paracellular permeability (CPP) and sensitivity, and (3) to examine the role of the proteinase-activated receptor-2 (PAR-2) activation and signalling cascade in this process. PATIENTS AND METHODS: Faecal enzymatic activities were assayed in healthy subjects and patients with IBS, ulcerative colitis and acute infectious diarrhoea. Following mucosal exposure to supernatants from control subjects and IBS-D patients, electromyographic response to colorectal balloon distension was recorded in wild-type and PAR-2-/- mice, and CPP was evaluated on colonic strips in Ussing chambers. Zonula occludens-1 (ZO-1) and phosphorylated myosin light chain were detected by immunohistochemistry. RESULTS: The threefold increase in faecal serine protease activity seen in IBS-D patients compared with constipation-predominant IBS (IBS-C) or infectious diarrhoea is of neither epithelial nor inflammatory cell origin, nor is it coupled with antiprotease activity of endogenous origin. Mucosal application of faecal supernatants from IBS-D patients in mice evoked allodynia and increased CPP by 92%, both of which effects were prevented by serine protease inhibitors and dependent on PAR-2 expression. In mice, colonic exposure to supernatants from IBS-D patients resulted in a rapid increase in the phosphorylation of myosin light chain and delayed redistribution of ZO-1 in colonocytes. CONCLUSIONS: Elevated colonic lumenal serine protease activity of IBS-D patients evokes a PAR-2-mediated colonic epithelial barrier dysfunction and subsequent allodynia in mice, suggesting a novel organic background in the pathogenesis of IBS.


Related Articles

  • Comparison of Methods for Detection of Blastocystis Infection in Routinely Submitted Stool Samples, and also in IBS/IBD Patients in Ankara, Turkey. Dogruman-Al, Funda; Simsek, Zahide; Boorom, Kenneth; Ekici, Eyup; Sahin, Memduh; Tuncer, Candan; Kustimur, Semra; Altinbas, Akif // PLoS ONE;2010, Vol. 5 Issue 11, p1 

    Background: This study compared diagnostic methods for identifying Blastocystis in stool samples, and evaluated the frequency of detection of Blastocystis in patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Results and Discussion: From a set of 105 stool...

  • Comparison of Psychological Factors in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Diseases. Faramarzi, Mahbobeh; Shokri-Shirvani, Javad; Kheirkhah, Farzan; Kianian, Maryam; Ghadiri, Maryam // British Journal of Medicine & Medical Research;2015, Vol. 5 Issue 2, p213 

    Introduction: Irritable bowel syndrome (IBS) and Inflammatory Bowel Disease (IBD) are two common diseases of lower gastrointestinal symptoms and discomfort. Although research has demonstrated the influence of psychological processes on gastrointestinal functions, few studies compared the role of...

  • NICE: faecal calprotectin.  // Pulse;Nov2013, p16 

    The article offers information on the diagnostics guidance from the National Institute for Care and Excellence regarding the use of faecal calprotectin testing to distinguish irritable bowel syndrome (IBS) from inflammatory bowel disease (IBD) in adult patients with gastrointestinal symptoms.

  • Paucicellular Lymphocytic Colitis: Is It a Minor Form of Lymphocytic Colitis? A Clinical Pathological and Immunological Study. Fernández-Bañares, Fernando; Casalots, Jaume; Salas, Antonio; Esteve, Maria; Rosinach, Mercè; Forné, Montserrat; Loras, Carme; Santaolalla, Rebeca; Espinós, Jorge; Viver, Josep M. // American Journal of Gastroenterology;May2009, Vol. 104 Issue 5, p1189 

    OBJECTIVES:It has been suggested that paucicellular lymphocytic colitis (PLC) should be considered to be part of the morphological spectrum of microscopic colitis. The aim of the study was to evaluate whether PLC may be considered to be a true microscopic colitis, and in this case, whether it is...

  • Opioid Bowel Dysfunction and Narcotic Bowel Syndrome: A Population-Based Study. Rok Seon Choung; Locke, G. Richard; Zinsmeister, Alan R.; Schleck, Cathy D.; Talley, Nicholas J. // American Journal of Gastroenterology;May2009, Vol. 104 Issue 5, p1199 

    OBJECTIVES:Opioid prescription use is increasing. Narcotic bowel syndrome (NBS) refers to chronic abdominal pain aggravated by narcotic use. Despite increasing narcotic use, NBS may be under-recognized. The aim of this study was to assess whether gastrointestinal (GI) symptoms in the community...

  • Comorbidity in Irritable Bowel Syndrome. Whitehead, William E.; Palsson, Olafur S.; Levy, Rona R.; Feld, Andrew D.; Turner, Marsha; Von Korff, Michael // American Journal of Gastroenterology;Dec2007, Vol. 102 Issue 12, p2767 

    BACKGROUND: Comorbid nongastrointestinal symptoms account for two-thirds of excess health-care costs in irritable bowel syndrome (IBS). OBJECTIVES: To determine whether IBS patients are at greater risk for specific comorbid disorders versus showing a general tendency to overreport symptoms;...

  • New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA/IBS diagnostic strategy. Pimentel, Mark; Hwang, Laura; Melmed, Gil Y.; Low, Kimberly; Vasiliauskas, Eric; Ippoliti, Andrew; Yang, Janet; Lezcano, Sheila; Conklin, Jeffrey L.; Sahakian, Ara // Digestive Diseases & Sciences;Jan2010, Vol. 55 Issue 1, p145 

    Modern methods of diagnosing diarrhea-predominant irritable bowel syndrome (D-IBS) require a "diagnosis of exclusion" approach. In this study we aim to test the diagnostic ability of using the fluctuation of frequency and consistency of bowel patterns in IBS to discriminate it from other causes...

  • Erratum to: Experiences of healing therapy in patients with irritable bowel syndrome and inflammatory bowel disease.  // BMC Complementary & Alternative Medicine;12/1/2015, Vol. 15, p1 

    No abstract available.

  • Stool DNA testing detected colorectal neoplasia in IBD patients.  // Hem/Onc Today;6/25/2013, Vol. 14 Issue 12, p33 

    The article discusses research which reveals the effectiveness of stool DNA tests in detecting high rates of colorectal neoplasia among patients with inflammatory bowel disease.


Read the Article


Sign out of this library

Other Topics